Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Cyclin D2 Antibodies:
anti-Mouse (Murine) Cyclin D2 Antibodies:
anti-Rat (Rattus) Cyclin D2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal Cyclin D2 Primary Antibody for WB - ABIN2801940
Ota, Suzuki, Nishikawa, Otsuki, Sugiyama, Irie, Wakamatsu, Hayashi, Sato, Nagai, Kimura, Makita, Sekine, Obayashi, Nishi, Shibahara, Tanaka, Ishii, Yamamoto, Saito, Kawai, Isono, Nakamura, Nagahari et al.: Complete sequencing and characterization of 21,243 full-length human cDNAs. ... in Nature genetics 2003
Show all 3 Pubmed References
Human Monoclonal Cyclin D2 Primary Antibody for IP, WB - ABIN967434
Meyerson, Harlow: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. in Molecular and cellular biology 1994
Show all 2 Pubmed References
Human Polyclonal Cyclin D2 Primary Antibody for ICC, IF - ABIN4301609
Danielsson, Wiking, Mahdessian, Skogs, Ait Blal, Hjelmare, Stadler, Uhlén, Lundberg: RNA deep sequencing as a tool for selection of cell lines for systematic subcellular localization of all human proteins. in Journal of proteome research 2013
Show all 2 Pubmed References
Human Polyclonal Cyclin D2 Primary Antibody for IF (cc), IF (p) - ABIN738366
Wang, Wu, Gao, Chen, Gu, Ding, Guo: Elevated toll-like receptor 3 inhibits pancreatic ?-cell proliferation through G1 phase cell cycle arrest. in Molecular and cellular endocrinology 2013
Mutation in the CCND2 gene is associated with acute myeloid leukemia (show BCL11A Antibodies).
data suggested that loss of CCND2 expression is closely associated with the promoter aberrant methylation
MiR (show MLXIP Antibodies)-497 significantly suppressed cell proliferation by arresting the cell cycle through the CCND2 protein.
cyclin D2 acts as regulator of cell cycle (show C13orf15 Antibodies) proteins affecting SAMHD1 (show SAMHD1 Antibodies)-mediated HIV-1 restriction in non-proliferating macrophages.
CCND2-AS1 (show PTGDR Antibodies) promotes glioma cells proliferation and growth in a process that involves Wnt (show WNT2 Antibodies) and beta-catenin (show CTNNB1 Antibodies)
CCND1 (show CCND1 Antibodies) is downregulated, whereas CCND2 is not, following ionizing radiation (IR) . Both CCND1 (show CCND1 Antibodies)- and CCND2-expressing MM cells arrested in S/G2 (show STRN3 Antibodies)/M, and did not differ in other cell-cycle proteins or sensitivity to IR.Differential expression of D-cyclin (show PCNA Antibodies) does not appear to affect cell-cycle response to IR, and is unlikely to underlie differential sensitivity to DNA damage.
the phosphorylation levels of ErbB2 (show ERBB2 Antibodies), ErbB3 (show ERBB3 Antibodies) and Akt (show AKT1 Antibodies) and the protein levels of cyclin D1 (show CCND1 Antibodies) were decreased by lapatinib treatment of HSC3, HSC4 and Ca9 (show CA9 Antibodies)-22 cells
miR (show MLXIP Antibodies)-155 overexpression plays a promoting role in the proliferative, migratory and invasive behavior of OSCC cells. Its effects on OSCC are possibly associated with its regulation of the BCL6 (show BCL6 Antibodies)/cyclin D2 axis.
Bioinformatics analysis further revealed cyclin D2 (CCND2) and AKT3 (show AKT3 Antibodies), putative tumor promoters, as potential targets of miR610. Data from reporter assays showed that miR610 directly binds to the 3'untranslated
this study shows that miR (show MLXIP Antibodies)-124-3p may negatively regulate the transcription of the STAT3 (show STAT3 Antibodies) by interfering with its 3'UTR (show UTS2R Antibodies), and the degradation of STAT3 (show STAT3 Antibodies) affects its downstream expression of such as p-STAT3 (show STAT3 Antibodies), CCND2 and MMP-2 (show MMP2 Antibodies)
NMB or NMBR (show NMBR Antibodies) silencing inhibited M-CSF (show CSF1R Antibodies)/c-Fms (show CSF1R Antibodies)-mediated downstream signaling pathways like activation of ERK (show EPHB2 Antibodies) and Akt (show AKT1 Antibodies) and induction of D-type cyclins, cyclin D1 (show CCND1 Antibodies) and D2.
Data (including data from studies in transgenic and knockout mice) suggest that Pkcz (protein kinase C zeta (show PRKCZ Antibodies)) activation is key for early compensatory pancreatic beta-cell proliferation in insulin (show INS Antibodies) resistance (overweight and diabetes type 2) by regulating downstream signal transduction components mTOR (mammalian target of rapamycin (show FRAP1 Antibodies) protein) and Ccnd2 (cyclin-D2).
miR (show MLXIP Antibodies)-26a regulated mouse hepatocyte proliferation by directly targeting the 3' untranslated regions of cyclin D2/cyclin E2 (show CCNE2 Antibodies).
NF-kappaB (show NFKB1 Antibodies)-miR (show MLXIP Antibodies)-195/497-Igf1r (show IGF1R Antibodies)/Insr (show INSR Antibodies)-Ccnd2/Ccne1 (show CCNE1 Antibodies) plays important roles in myogenesis.
Loss of N-myc (show MYCN Antibodies) significantly impairs the Sonic hedgehog (show SHH Antibodies) signaling pathway and disrupts the expression of cell cycle effectors with a significant reduction of Ccnd2.
Activation of the ERK1/2 (show MAPK1/3 Antibodies) signalling pathway, increased phosphorylation of c-myc (show MYC Antibodies) and significantly increased expression of cyclin D2 protein, are demonstrated.
Hippocampus-dependent learning was not generally impaired in Ccnd2 knockout mice, but specifically functional aspects of maze learning were affected.
FGF2 signaling results in the phosphorylation of Erk1/2, and activation of c-Fos and c-Jun that lead to elevated cyclin D mRNA levels.
Islet ARNT (show ARNT Antibodies) increases in normal murine pregnancy and beta-cell ARNT (show ARNT Antibodies) is required for cyclinD2 induction and increased beta-cell proliferation in pregnancy.
maternal dietary betaine supplementation during gestation inhibits hepatic cell proliferation in neonatal piglets, at least partly, through epigenetic regulation of hepatic CCND2 and PSEN1 (show PSEN1 Antibodies) genes via a STAT3 (show STAT3 Antibodies)-dependent pathway
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors.
, G1/S-specific cyclin-D2
, G1/S-specific cyclin D2
, vin-1 proto-oncogene